Announcements Trials

Browse Landscape

Phase

Status

Completed 125 Recruiting 39 Terminated 34 Active not recruiting 31 Unknown 29 Withdrawn 9 Not yet recruiting 4 No longer available 1 Enrolling by invitation 1 Available 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 73 Breast Neoplasms 70 Colorectal Neoplasms 39 Prostatic Neoplasms 37 Carcinoma, Non-Small-Cell Lung 26 Lung Neoplasms 25 Stomach Neoplasms 20 Carcinoma, Hepatocellular 20 Uterine Cervical Neoplasms 19 Pancreatic Neoplasms 15 Anxiety Disorders 15 Leukemia, Myeloid, Acute 14 Hematologic Neoplasms 13 Colonic Neoplasms 13 Brain Neoplasms 13 Urinary Bladder Neoplasms 12 Lymphoma, Follicular 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Head and Neck Neoplasms 11 Esophageal Neoplasms 10 Diabetes Mellitus 10 Ovarian Neoplasms 9 Melanoma 9 Liver Neoplasms 9 Sarcoma 8 Rectal Neoplasms 8 Pulmonary Disease, Chronic Obstructive 8 Multiple Myeloma 8 Esophageal Squamous Cell Carcinoma 8 Disease 8

Interventions

Ruthenium-106 1 Radiotherapy 1 Melphalan 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Uveal Melanoma × Clear all

NCT05893654 2025-09-15

MELCOM

Hospital das Clínicas de Ribeirão Preto

Phase 1/2 Enrolling by invitation

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡